Stuart W. Peltz

2021

In 2021, Stuart W. Peltz earned a total compensation of $11M as Chief Executive Officer at PTC Therapeutics, a 4% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$835,300
Option Awards$7,550,900
Salary$768,750
Stock Awards$1,835,124
Other$32,249
Total$11,022,323

Peltz received $7.6M in option awards, accounting for 69% of the total pay in 2021.

Peltz also received $835.3K in non-equity incentive plan, $768.8K in salary, $1.8M in stock awards and $32.2K in other compensation.

Rankings

In 2021, Stuart W. Peltz's compensation ranked 885th out of 12,415 executives tracked by ExecPay. In other words, Peltz earned more than 92.9% of executives.

ClassificationRankingPercentile
All
885
out of 12,415
93rd
Division
Manufacturing
290
out of 5,505
95th
Major group
Chemicals And Allied Products
97
out of 2,375
96th
Industry group
Drugs
82
out of 2,096
96th
Industry
Pharmaceutical Preparations
53
out of 1,546
97th
Source: SEC filing on April 28, 2022.

Peltz's colleagues

We found four more compensation records of executives who worked with Stuart W. Peltz at PTC Therapeutics in 2021.

2021

Emily Hill

PTC Therapeutics

Chief Financial Officer

2021

Mark Boulding

PTC Therapeutics

Chief Legal Officer

2021

Neil Almstead

PTC Therapeutics

Chief Technical Operations Officer

2021

Eric Pauwels

PTC Therapeutics

Chief Business Officer

News

In-depth

You may also like